Ouster stock price target kept at $38 by Northland on product launch

Ouster reported Q1 2026 revenue of $49 million, ahead of expectations, and the stock has surged 256% over the past year, including a 7%+ premarket gain after a 9% move yesterday. The company also launched its Rev8 lidar platform and announced Nvidia integration, reinforcing its technology narrative despite an EPS miss of -$0.28 versus -$0.12 expected. Northland kept an Outperform rating and $38 target unchanged, while Oppenheimer raised its target to $42 from $40.

Analysis

The market is starting to price OUST less like a cyclical sensor vendor and more like an early platform winner in autonomy/robotics, which matters because multiple expansion can outrun fundamentals for several quarters once a design-wins narrative takes hold. The Nvidia tie-in is the real second-order catalyst: it lowers friction for channel access and validates interoperability, which can accelerate procurement decisions even if near-term revenue guidance stays unchanged. That said, the biggest hidden lever is not the current quarter—it is whether Rev8 becomes a reference architecture that forces competitors to re-price performance, especially around resolution and color/perception workloads.

The setup is vulnerable to a classic “good product, bad numbers” reversal. If gross margin or opex leverage does not inflect by the next 1-2 quarters, the market may eventually rotate from story valuation to cash burn scrutiny, especially after a multi-bag move over the past year. Any delay in converting product launches into backlog, or any evidence that the Nvidia association is more marketing than volume catalyst, could compress the multiple quickly.

Consensus appears to be underestimating how much of the upside is already in the stock from here. With the move now driven by headlines and analyst reiterations rather than fresh guidance upside, the asymmetry shifts: incremental good news may only sustain the rally, while a single miss on margins, bookings, or forward commentary can trigger a sharp de-rating. The more interesting bullish case is not outright share appreciation from here, but a volatility expansion trade if the company can prove that Rev8 drives a step-function in attach rate over the next two reporting cycles.

Key Decisions for Investors

• Take profits on existing OUST longs into strength over the next 1-3 sessions; the near-term setup is momentum-led and fragile after a vertical move, with limited upside unless management raises medium-term guidance.
• For investors wanting exposure, prefer a call spread in OUST 1-2 quarters out rather than outright equity; this captures continuation from product/catalyst momentum while capping risk if valuation compresses.
• Pair trade: long NVDA / short OUST on any further premarket squeeze if OUST trades materially above analyst targets; the market is likely over-assigning immediate monetization to the partnership while NVDA retains diversified upside from ecosystem adoption.
• If holding OUST into the next earnings cycle, use a stop on any guide-down or margin miss; the stock’s elevated beta means disappointment could mean a 15-25% drawdown in days, not weeks.
• Watch for confirmation in bookings/backlog commentary and channel adoption over the next 60-90 days; add only if Rev8 is shown to be translating into measurable commercial traction, not just narrative support.